Word

V

Status

Pending

Status Code

641

Status Date

Thursday, November 30, 2023

Serial Number

97815175

Mark Type

3000

Filing Date

Tuesday, February 28, 2023

Trademark Owner History

Veracyte, Inc.

Classifications

5 Kits for in vitro diagnostic testing; Reagents for medical use; Molecular diagnostic assays; Medical preparations and substances; Diagnostic test kits for medical use comprising reagents; Medical diagnostic test kits for detecting pathogens; Clinical medical diagnostic reagents, medical diagnostic assays for medical and diagnostic purposes for testing genetic material; Clinical, genetic and specialized tests related to scientific and clinical diagnostic equipment; Chemicals, assays, reagents and kits consisting primarily of chemicals, assays, and reagents for medical testing and diagnostic purposes; Medical diagnostic reagents, and kits comprised of medical diagnostic reagents, collection tubes, buffers, tube holders, transport bags, and instruction sheets, for diagnostic testing in the fields of diagnostics, medical diagnostics, clinical diagnostics, companion diagnostics, medical treatment, medical research, clinical research, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, breast cancer, lung cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases; Testing kits and assays for use in diagnostics and other medical tests in the fields of diagnostics, medical diagnostics, clinical diagnostics, companion diagnostics, medical treatment, medical research, clinical research, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, breast cancer, lung cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases; Tests designed to isolate and extract cells for genetic analysis comprised of reagents for medical diagnostic use

1 Reagents for scientific or research use; Diagnostic tests and test kits primarily composed of reagents for determination of genomic and transcriptomic information for scientific or research purposes; Testing kits and assays for use in scientific or research in the fields of diagnostics, medical diagnostics, clinical diagnostics, companion diagnostics, medical treatment, medical research, clinical research, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, breast cancer, lung cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases; Biological agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for scientific and research use; Diagnostic reagents and preparations, other than for veterinary use; Kits comprised primarily of biological reagents and comprised secondarily of a protocol in the form of printed instructions for use thereof for scientific and research purposes; Tests designed to isolate and extract cells for genetic analysis comprised of reagents for scientific or research purposes; Reagents and molecule or cell markers for scientific or research purposes

44 Medical services; Medical research services; Medical diagnostic testing services; Medical testing for diagnostic or treatment purposes; Medical analysis services for diagnostic and treatment purposes; Medical diagnostic testing services in the fields of oncology, cancer, and diseases; Genetic analysis and reporting services for medical diagnostic purposes; Medical diagnostic testing, monitoring and reporting services in the fields of diagnostics, medical diagnostics, clinical diagnostics, companion diagnostics, medical treatment, medical research, clinical research, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, breast cancer, lung cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases; Nucleic acid sequencing and analysis services for medical diagnostic and treatment purposes; Genomic and transcriptomic sequencing and analysis services for medical diagnostic and treatment purposes; Genetic analysis and reporting services for medical diagnostic and treatment purposes

42 Clinical research; Laboratory research; Laboratory services; Laboratory testing services; Laboratory testing and reporting services for use in research and development for oncology, cancers, and diseases; Scientific and medical research and development services; Research and development services for others in the field of diagnostic tests, chemicals, compounds and devices; Research and development of new diagnostic tests, clinical products, diagnostic agents and assays; Nucleic acid sequencing, screening, and analysis services for medical research purposes; Genomic and transcriptomic sequencing, screening, and analysis services for medical research purposes; Genetic analysis and reporting services for medical research purposes; Providing diagnostic services for others in the fields of diagnostics, medical diagnostics, clinical diagnostics, companion diagnostics, medical treatment, medical research, clinical research, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, breast cancer, lung cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases; Chemical screening analysis and diagnostic services for others; Scientific and technological research and diagnostic services; Advisory, consultative and telephone helpline services relating to the use of assays and reagents for use in biochemical analysis and medical diagnostics; Information and advisory services in the fields of diagnostics, medical diagnostics, clinical diagnostics, companion diagnostics, medical treatment, medical research, clinical research, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, breast cancer, lung cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases; Providing non-downloadable computer software for medical diagnostics and research; Non-downloadable software for data collection, management, and analysis of genetic information for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; Non-downloadable software for use in data analysis in the fields of diagnostics, medical diagnostics, clinical diagnostics, companion diagnostics, medical treatment, medical research, clinical research, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, breast cancer, lung cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases

The mark consists of the letter V stylized with a solid geometric shape.
Color is not claimed as a feature of the mark.

Trademark Events

Feb 22, 2024

Application Extension Granted/Receipt Provided

Feb 22, 2024

Application Extension To Response Period - Received

Nov 30, 2023

Notification Of Non-Final Action E-Mailed

Nov 30, 2023

Non-Final Action E-Mailed

Nov 30, 2023

Non-Final Action Written

Nov 29, 2023

Assigned To Examiner

Mar 21, 2023

Notice Of Design Search Code E-Mailed

Mar 19, 2023

New Application Office Supplied Data Entered

Mar 3, 2023

New Application Entered